Freshfields Bruckhaus Deringer advised Affimed N.V. (Nasdaq: AFMD) on the deal. Affimed N.V. announced its strategic collaboration with Artiva Biotherapeutics Inc. (‘Artiva‘), likewise an immuno-oncology company, to jointly...
This content is for Standard 1 Year members only. LoginJoin Now